Crossmark

Development of a double-recombinant antibody sandwich ELISA for quantitative detection of epsilon toxoid concentration in inactivated Clostridium perfringens vaccines

Crossref DOI link: https://doi.org/10.1186/s12917-020-02572-4

Published Online: 2020-09-29

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alibeiki, Maryam

Golchin, Mehdi

Tabatabaei, Mohammad
License Information

Text and Data Mining valid from 2020-09-29

Version of Record valid from 2020-09-29
More Information

Article History

Received: 30 April 2020

Accepted: 15 September 2020

First Online: 29 September 2020

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no conflicts of interest associated with this study.

Document is current

Any future updates will be listed below